Investing in a Bear Market - Seeking Alpha in DeSci

The panel includes Zen Chu as moderator, Dr. Friederike Ernst, James Brodie, Elad Verbin and Chris Leiter. They are investors and founders with expertise in biotech, blockchain, and decentralized science (DeSci). They discuss topics related to DeSci, its potential impact on various fields, and the challenges it faces.

The panelists touch on subjects such as:

The potential of DeSci to address inefficiencies in academia, the importance of eliminating barriers to entry for researchers, and the power of patient advocacy groups in driving medical innovation.

Disease-specific DAOs: The audience asks about the potential for DAOs (decentralized autonomous organizations) in addressing specific diseases or conditions, such as obesity and psychiatric disorders. Panelists suggest that DAOs can focus on collecting valuable human data sets in these areas.

Psychological Conditions: The discussion delves into the challenges of studying psychological conditions and suggests that DAOs could be formed to collect longitudinal data on such conditions.

Branches of Science: The panelists consider other branches of science where decentralized approaches could make a significant difference, including computational chemistry, materials science, AI, and space exploration.

Engaging with Regulators: There's a mention of the importance of engaging with regulators early on in decentralized science projects to understand their requirements and guidelines.